Upexi (NASDAQ:GRVI – Get Rating) and Hero Technologies (OTCMKTS:HENC – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Risk and Volatility

Upexi has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Hero Technologies has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500.

Valuation and Earnings

This table compares Upexi and Hero Technologies' revenue, earnings per share (EPS) and valuation.

Institutional and Insider Ownership

1.8% of Upexi shares are held by institutional investors. 55.0% of Upexi shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Upexi and Hero Technologies' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and target prices for Upexi and Hero Technologies, as reported by MarketBeat.com.

Summary

Upexi beats Hero Technologies on 8 of the 8 factors compared between the two stocks.

About Upexi

(Get Rating)

Grove, Inc., through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors. It also operates annual tradeshow related to the CBD industry in the United States. The company was incorporated in 2018 and is headquartered in Henderson, Nevada.

About Hero Technologies

(Get Rating)

Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company was incorporated in 2004 and is headquartered in Dover, Delaware.

Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.